Karyotypic complexity of the NCI-60 drug-screening panel
Proteomic Profiling of the NCI-60 Cancer Cell Lines Using New High-density Reverse-phase Lysate Microarrays
Transcriptomic Analysis of the NCI-60 Cancer Cell Lines
Diagnostic Markers That Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling
Apoptosis induced by topoisomerase inhibitors
Impact of p53-knockout and Topotecan Treatment on Gene Expression Profiles in Human Colon Carcinoma Cells: A Pharmacogenomics Study.
MatchMiner: A Tool for Batch Navigation among Gene and Gene Product Identifiers
GoMiner: A Resource for Biological Interpretation of Genomic and Proteomic Data
Cell cycle and checkpoints in oncology: new therapeutic targets
This web site is a development of the Genomics and Pharmacology Facility, Developmental Therapeutics Branch (DTB), Center for Cancer Research (CCR), National Cancer Institute (NCI).